drugset / Trial / NCT00649311

A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension

NCT00649311

Phase 2 Terminated 248 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose this study is to compare the efficacy of eplereonone and losartan in patients with mild to moderate hypertension.

Timeline

Start
2003-04
Primary completion
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Eplerenone Unknown 50 mg Oral
Comparator Losartan Other / unclassified 50 mg Oral

Indications